Vitamin B3 shows promise in reducing skin cancer risk for leukemia patients
NCT ID NCT04844528
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This study tests whether taking nicotinamide (a form of vitamin B3) twice daily can lower the risk of new non-melanoma skin cancers in people with chronic lymphocytic leukemia (CLL) who have already had at least one skin cancer. About 86 participants will be randomly assigned to receive either nicotinamide or a placebo for one year, then all will receive nicotinamide for another year. The goal is to see if this simple vitamin can help control skin cancer development in this higher-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huntsman Cancer Institute at University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.